Armen Asik MD

Gastrointestinal Cancer, Hematologic Oncology

Assistant Professor, Medicine, UMass Medical School

3350 Main StSpringfield, MA 01199
Phone+1 413-794-9338
Fax+1 413-794-9754

Dr. Asik is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Asik's full profile Already have an account?

Education & Training

University of Illinois College of Medicine at PeoriaResidency, Gastroenterology, 2019 - 2025
St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
Hackensack Meridian Health/Englewood Hospital and Medical CenterResidency, Internal Medicine, 1990 - 1993
Istanbul University FomClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1993 - 2027
IL State Medical License 1995 - 1999

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification HealthShare, InterSystems Corp., 2011, 2013-2014
CMS Meaningful Use Stage 1 Certification eHealth ecoSystem, MedSeek, Inc., 2011, 2013-2014
CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2011, 2013-2014

Clinical Trials

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
COMPLETED
PHASE2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
COMPLETED
PHASE3

Publications & Presentations

PubMed

10 citations
Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: A marker of disease activity
Kah Poh Loh, Ankit Kansagra, Armen Asik, Syed Ali, Saurabh Dahiya
Rare Tumors. 2015-02-11